Sensex, Nifty maintain morning gains; Ajanta Pharma most active

Epic Research Update : Ajanta Pharma
Epic Research Update : Ajanta Pharma

Benchmark indices retained morning gains with the Nifty holding 8400 level ahead of expiry of January derivative contracts tomorrow and Union Budget that will be presented on February 1.

The 30-share BSE Sensex gained 128.68 points at 27246.02 and the 50-share NSE Nifty rose 45.30 points to 8436.80. The broader markets also gained half a percent on positive breadth.

About 1411 shares advanced against 925 declining shares on the exchange.

Ajanta Pharma was the most active share on the National Stock Exchange, down more than 4 percent after the company got an import alert from USFDA for selling an unapproved drug in the US from its Aurangabad facility. In this case, Ajanta was found marketing its erectile dysfunction drug Kamarga in United States without proper approvals. Kamarga uses an active ingredient Sildenafil Citrate (a.k.a Viagra).

HCL Technologies was also in active stock list, down over a percent after reporting in line earnings and maintaining FY17 revenue guidance.

ICICI Bank, Yes Bank and Tata Communications were other most active shares.
For more information and best EQUITY TIPS,

Call us ✆ – 0731-6642300 or Visit http://www.epicresearch.co

Connect with our social media sites
Previous
Next Post »